Radboud University Medical Center to Convert Cancer Tests to PGM, Starting with BRCA1/2 Test | GenomeWeb

Radboud University's Medical Center in Nijmegen, The Netherlands, is developing a hereditary breast cancer screening test on Life Technologies' Ion Torrent PGM that it plans to begin offering to patients in March.

By the end of the year, the lab plans to offer all cancer mutational testing on the PGM.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.